Bosentan in Systemic Sclerosis
NCT01395732
Connective Tissue Diseases, Digital Ulcers
Amsterdam, Netherlands
View Trial DetailsNCT Number: NCT01377090
The CAP study is a multicenter, observational, clinical study in patients with systemic sclerosis. The study aims at determining the usefulness of nailfold videocapillaroscopy and patient-specific disease-related factors in predicting the occurrence of digital ulcers within a 6-month observation period. Patients with cutaneous forms of systemic sclerosis (limited or diffuse), with or without history of digital ulceration are eligible. The study will enroll 500 patients at 70 centers.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Medizinische Universität Graz, Graz, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For all patients:
For patients with no history of digital ulcers (DU) and no DU at enrollment only:
Exclusion criteria
Time frame: 6 months
Occurrence of the first new digital ulcer (DU) within 6 months
Actelion
Industry
A Multicenter, Prospective Cohort Study Using Nailfold VideoCAPillaroscopy(NVC) and Other Factors to Determine the Risk of Developing Digital Ulceration in Patients With Systemic Sclerosis (SSc)
Acronym: CAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01395732
Connective Tissue Diseases, Digital Ulcers
Amsterdam, Netherlands
View Trial DetailsNCT00077584
Connective Tissue Diseases, Digital Ulcers
View Trial DetailsNCT07717060
Connective Tissue Diseases, Digital Ulcers
View Trial DetailsNCT02975960
Connective Tissue Diseases, Gangrene
Seoul, South Korea
View Trial Details